The US Department of Justice has charged a former CFO and a former head of corporate communications for allegedly conducting an insider trading scheme.
Eli Lilly and Co received a subpoena late last week from the US Department of Justice (DOJ), requesting certain documents, as part of a probe into its manufacturing site in Branchburg, New Jersey.